ProPhase Labs Inc (PRPH)
2.19
+0.05
(+2.34%)
USD |
NASDAQ |
Nov 04, 16:00
2.19
0.00 (0.00%)
Pre-Market: 20:00
ProPhase Labs Enterprise Value: 53.59M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 53.59M |
| November 01, 2024 | 52.63M |
| October 31, 2024 | 55.50M |
| October 30, 2024 | 55.11M |
| October 29, 2024 | 54.73M |
| October 28, 2024 | 57.59M |
| October 25, 2024 | 57.40M |
| October 24, 2024 | 55.78M |
| October 23, 2024 | 55.69M |
| October 22, 2024 | 58.36M |
| October 21, 2024 | 57.59M |
| October 18, 2024 | 57.59M |
| October 17, 2024 | 58.36M |
| October 16, 2024 | 57.21M |
| October 15, 2024 | 55.40M |
| October 14, 2024 | 57.59M |
| October 11, 2024 | 57.79M |
| October 10, 2024 | 54.35M |
| October 09, 2024 | 55.50M |
| October 08, 2024 | 56.07M |
| October 07, 2024 | 58.93M |
| October 04, 2024 | 58.74M |
| October 03, 2024 | 57.59M |
| October 02, 2024 | 57.59M |
| October 01, 2024 | 54.73M |
| Date | Value |
|---|---|
| September 30, 2024 | 57.98M |
| September 27, 2024 | 57.59M |
| September 26, 2024 | 55.11M |
| September 25, 2024 | 53.02M |
| September 24, 2024 | 53.78M |
| September 23, 2024 | 57.21M |
| September 20, 2024 | 56.45M |
| September 19, 2024 | 59.69M |
| September 18, 2024 | 58.55M |
| September 17, 2024 | 61.98M |
| September 16, 2024 | 57.59M |
| September 13, 2024 | 58.55M |
| September 12, 2024 | 61.22M |
| September 11, 2024 | 63.32M |
| September 10, 2024 | 64.46M |
| September 09, 2024 | 64.27M |
| September 06, 2024 | 64.27M |
| September 05, 2024 | 60.07M |
| September 04, 2024 | 61.22M |
| September 03, 2024 | 60.07M |
| August 30, 2024 | 63.13M |
| August 29, 2024 | 57.59M |
| August 28, 2024 | 56.45M |
| August 27, 2024 | 56.74M |
| August 26, 2024 | 58.55M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
10.35M
Minimum
Jul 02 2020
211.63M
Maximum
Jul 11 2022
89.03M
Average
91.06M
Median
Feb 28 2024
Enterprise Value Benchmarks
| Fonar Corp | 28.39M |
| XWELL Inc | -0.7802M |
| Applied DNA Sciences Inc | -8.715M |
| Veracyte Inc | 2.454B |
| OncoCyte Corp | 39.57M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.153M |
| Revenue (Quarterly) | 2.474M |
| Total Expenses (Quarterly) | 10.30M |
| EPS Diluted (Quarterly) | -0.33 |
| Gross Profit Margin (Quarterly) | -19.24% |
| Profit Margin (Quarterly) | -248.7% |
| Earnings Yield | -68.04% |
| Normalized Earnings Yield | -68.04 |